These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 20500130)

  • 1. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.
    Cao F; Zhang X; Ping Q
    Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
    Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
    Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
    Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
    Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation.
    Lihong W; Xin C; Yongxue G; Yiying B; Gang C
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1402-10. PubMed ID: 23944837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
    Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
    Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
    M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
    Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.
    Jones DS; Bruschi ML; de Freitas O; Gremião MP; Lara EH; Andrews GP
    Int J Pharm; 2009 May; 372(1-2):49-58. PubMed ID: 19429268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
    Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
    Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
    Mansour M; Mansour S; Mortada ND; Abd Elhady SS
    Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of xanthan gum and guar gum on in situ gelling ophthalmic drug delivery system based on poloxamer-407.
    Bhowmik M; Kumari P; Sarkar G; Bain MK; Bhowmick B; Mollick MM; Mondal D; Maity D; Rana D; Bhattacharjee D; Chattopadhyay D
    Int J Biol Macromol; 2013 Nov; 62():117-23. PubMed ID: 23988556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of a brinzolamide drug-resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery.
    Li J; Liu H; Liu LL; Cai CN; Xin HX; Liu W
    Chem Pharm Bull (Tokyo); 2014; 62(10):1000-8. PubMed ID: 25099146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, pharmacokinetics and pharmacodynamics of ophthalmic thermosensitive in situ hydrogel of betaxolol hydrochloride.
    Huang W; Zhang N; Hua H; Liu T; Tang Y; Fu L; Yang Y; Ma X; Zhao Y
    Biomed Pharmacother; 2016 Oct; 83():107-113. PubMed ID: 27470557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation and properties of thermosensitive in situ gel for ophthalmic formulation containing pearl hydrolyzate].
    Song LN; Li HR; Wang HY; Li Z; Zhao WC; Lu FZ; Li SM
    Yao Xue Xue Bao; 2016 Oct; 51(10):1622-8. PubMed ID: 29932618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on preparation of Dange Mingmu in-situ forming eye gel].
    Wang Z; Wang Y; Li H; Zang C; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):46-51. PubMed ID: 22741460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model.
    Sultana Y; Aqil M; Ali A; Zafar S
    Pharm Dev Technol; 2006; 11(3):313-9. PubMed ID: 16895842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of in situ gelling and bio adhesive 5-Fluorouracil enema.
    Wang LL; Zheng WS; Chen SH; Fang XQ
    PLoS One; 2013; 8(8):e71037. PubMed ID: 23976976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.
    Liu Y; Zhu YY; Wei G; Lu WY
    Eur J Pharm Sci; 2009 Jun; 37(3-4):306-12. PubMed ID: 19491020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.